Rusan Pharma achieves key GMP approvals for Australian and Brazilian markets EP News Bureau Dec 16, 2024 Rusan Pharma expands its global footprint with TGA and ANVISA GMP certifications for its transdermal patch and oral film…
Global opioid use disorder market to reach $3.7 bn by 2028: GlobalData EP News Bureau Sep 24, 2020 The main driver of growth will be the launch of reformulations of buprenorphine, in particular, extended-release formulations
